Entries tagged "Illumina Inc."

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Illumina Inc.."

12 result(s) displayed (1 - 12 of 17)

As Roche backs off, Illumina buys Verinata

The gene sequencing specialist makes a deal that could give it a stranglehold on the market for prenatal testing on the same day that the Swiss pharmaceutical giant signals that it's no longer interested in a buyout of the San Diego company. Continue reading

Posted on January 7, 2013 2:16 PM

Complete Genomics chief returns fire on CFIUS warning

The company's chairman says attacks by Illumina are motivated by a desire to maintain China's BGI as a customer. Continue reading

Posted on December 14, 2012 8:25 AM

Analyst urges Roche back to acquisition trail

Jefferies & Co.'s Jeffrey Holford identifies a few potential targets for the Swiss pharma giant, but while other analysts agree an earnings slide is coming, they don't share his M&A yearning. Continue reading

Posted on September 27, 2012 4:01 PM

Rivals eye Dewey's Silicon Valley M&A lawyers

Richard Climan and his group of M&A lawyers were the talk of Silicon Valley when they left Cooley for Dewey & LeBoeuf and speculation is once again swirling. Continue reading

Posted on May 4, 2012 8:26 AM

Roche won't extend $6.3B Illumina offer

The drug giant all but abandons its $6.3 billion unsolicited bid for the gene-sequencing specialist. Continue reading

Posted on April 18, 2012 11:19 AM

Roche first quarter results underscore Illumina appeal

The drug giant's flat first-quarter revenues come just a day after Roche reiterated its calls for negotiations with the board of the gene sequencing specialist. Continue reading

Posted on April 12, 2012 8:45 AM

Illumina investors expect only modest Roche boost

With three proxy firms advising shareholders against its hostile approach, Roche will likely raise its unsolicited offer for the gene sequencing specialist, but not by much Continue reading

Posted on April 10, 2012 2:06 PM

Roche lashes out at Illumina board

Investors have dwindling hope that the hostile bidder will increase its offer for a second time Continue reading

Posted on April 3, 2012 9:15 AM

Roche raises Illumina offer by 15%

The San Diego company tells shareholders to take no action while it considers the sweetened bid that values its stock at close to $6.3 billion. Continue reading

Posted on March 29, 2012 8:15 AM

Roche extends Illumina offer

The next closing date for the hostile $5.7 billion offer falls just after a critical shareholders' meeting at which Roche will try to gain a majority of its target's board seats Continue reading

Posted on March 26, 2012 9:10 AM

FTC requests information in Roche-Illumina probe

The FTC asked for further information on Roche's microarray, or gene chips, business Continue reading

Posted on March 14, 2012 1:15 PM

Roche extends hostile Illumina bid

Shareholders in the gene-sequencing specialist continue to bet on a sweetened offer Continue reading

Posted on February 27, 2012 10:38 AM

Movable Type search results powered by Fast Search